59P Efficacy of derazantinib in intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions, mutations or amplifications

Mitesh J. Borad, M. Javle, W.L. Shaib, K. Mody, F. Bergamo, W.P. Harris, N. Damjanov, T. Macarulla, G. Brandi, G. Masi, Michele Droz Dit Busset, Alex Boncompagni, M. Dimova-Dobreva, M. Engelhardt, M. Saulay, T.R. Halfdanarson, J. Knox, G.K. Abou-Alfa, N. Personeni, V. Mazzaferro